SlideShare a Scribd company logo
1 of 25
Download to read offline
a customer and science-focused
contract development & manufacturing organization
HOST CELL PROTEIN ANALYSIS
BY MASS SPECTROMETRY
Michael J Nold, Ph.D.
Director, Mass Spectrometry Core Facility
• Challenges with HCPs
• HCP Spectral Library Generation
• Process Clearance Monitoring
HCP– Analysis by Mass Spectrometry
Overview
2
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
• HCPs are impurities generated when recombinant
proteins are manufactured. Recombinant proteins are
frequently expressed in host cells from various cell
lines.
• Mammalian, Microbial, Bacterial, Yeast, Plant, Insect
• Residual HCPs may affect product quality, safety and
efficacy.
• Toxicity, immune response to target, adjuvant effect, augment
ADA response, bioactivity, product stability, product potency
• Risks from a variety of factors
• Dosing and dose frequency, patient demographics, route of
administration
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
Many Challenges:
• Variability of host cell substrates
• Large number of protein analytes
• Variability of protein population during upstream processing
• Parental cell line, cell age, cell viability, feeding strategy, etc.
• Dynamic range difference between DP and HCPs ( ≥e6 )
• Detection of HCPs that are not immunogenic à Immunoassay
may miss these
• HCP population can change during process development
• HCPs may copurify with DP – “Hitchhiker” effect
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
Mass Spectrometry Challenges:
• Column capacity, sample loading
• DP overload on column
• Mass spectrometer sensitivity
• Dynamic range for ion detections
• False positives, negatives
• Ion statistics for identification, quantitation
• Speed – Data to results to support process development
• Does library reflect the process?
• Time to generate a new library
KBI HCP Reagents and Applications
PHYSICAL
CHEMICAL
ATTRIBUTE #1
PHYSICAL
CHEMICAL
ATTRIBUTE #3
PHYSICAL
CHEMICAL
ATTRIBUTE #2
6
HCP– MS Workflow Overview
LCMS via ACQUITY/6600 TripleTOF
Spectral Library Generation Sample Analysis
Data Processing and Library Searching
Data
Independent
Acquisition
SWATH MS
Data
Dependent
Acquisition
LC-MS/MS
CHO HCCF
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
Spectral
Library
1% FDR
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
List of
identified
proteins and
peptides
Spectral
library
matching
based on
set search
criteria and
thresholds
Sample
7
HCP– MS Workflow Overview
LCMS via ACQUITY/6600 TripleTOF
Spectral Library Generation Sample Analysis
Data Processing and Library Searching
Data
Independent
Acquisition
SWATH MS
Data
Dependent
Acquisition
LC-MS/MS
CHO HCCF
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
Spectral
Library
1% FDR
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
List of
identified
proteins and
peptides
Spectral
library
matching
based on
set search
criteria and
thresholds
Sample
7
HCP Spectral Library Generation
Sample Preparation on the Protein and Peptide Level
Process
Samples
1D Analysis - No peptide level fractionation
Process
Samples
2D Analysis - High pH RP-HPLC peptide level fractionation
Fraction 3
Fraction 2
Fraction 1
Fraction 4
Fraction 5
Peptide level fractionation of 5 of
the 8 protein fractionated samples
PHYSICAL
CHEMICAL
ATTRIBUTE #1
PHYSICAL
CHEMICAL
ATTRIBUTE #3
PHYSICAL
CHEMICAL
ATTRIBUTE #2
8
HCP Spectral Library Generation
Sample Load Optimization
• Load Optimization Goal:
achieve a dynamic range of
≥ 3 logs at the protein level for
each experiment.
• Utilize the ITC (ion
transmission control) Count
Conversion of the TOF MS TIC
to determine the appropriate
amount on column: optimized
load when the TOF MS TIC
apex is between 10-20%.
• ITC: dynamically adjusts
percent of the ion beam
(voltage gate) according to an
observed TIC signal to prevent
saturation.
• ITC Count Conversion plots the
ITC voltage gate response:
no signal / gate fully open = 100%
saturation / gate fully closed = 0%
TOF MS TIC – SWATH
ITC Count Conversion of the TOF MS TIC – SWATH
TOF MS TIC Apex
9
1.E+04
1.E+06
1.E+08
0 10 20 30 40 50
ProteinArea
Protein Number
Log Plot of Protein Dynamic Range
HCP Spectral Library Generation
Sample Load Optimization – Depth of Database
• ADH: spiked in all samples at 300 fmol/µL**, used as a system suitability test and
the signal response for relative quantitation.
• PCM: spiked in all samples at 100 fmol/µL**, used as a retention time calibrator
allowing for retention time alignment on any chromatographic system or timescale.
** Concentration of ADH and PCM is relative to 2 µg/µL of total HCP concentration.
XIC - Yeast Alcohol Dehydrogenase (ADH)
XIC - Peptide Calibration Mix (PCM)
Graph generated using the HCPs identified in sample S3 to
conceptually show the dynamic range of identified HCPs.
10
HCP Spectral Library Generation
IDA Library Data Collection and Processing
ProteinPilot™ data processing
w/ Paragon™ Algorithm.
IDA spectral library
Filter IDA spectral library
based on acceptance
criteria.
• Acceptance Criteria for Library:
• 1% FDR
• No modifications or clipped peptides
• Minimum of 2 peptide identifications per
protein
• Peptide Confidence Level: 95%
• 10 ppm mass error tolerance
• 2/2 identification replication
Acquire IDA data in duplicate for
each of 28 HCP samples/fractions.
11
HCP Spectral Library Generation
Contributions from 3 physiochemical preparations & fractionation
Physiochemical
Attribute 1
1850 Proteins
Physiochemical
Attribute 2
2925 Proteins
Physiochemical
Attribute 3
2137 Proteins
3802 Proteins
114
304
1047
598
976
385
378
• HCPs are monitored from samples
collected along a purification process,
either for process development
feedback, or monitoring a final process
for one or more batches.
• Samples are analyzed in triplicate, and
identifications will have to meet a set of
criteria at both peptide and protein
levels.
• Results include the list of identified
HCPs, and relative quantitative
information.
• As an illustration, samples were
obtained from the last four points of
sampling from one of our programs.
Protein A
Viral Inactivation
AEX* Based Polishing
(Flow Through mode)
CEX* Based Polishing
Viral Filtration
UF/DF
Clarified Harvest
*May be mixed mode
S3
S4
S5
S6
HCP Process Clearance Monitoring
Stand Alone, ELISA Support, or Process Development Support
7193 ppm
125 ppm
10 ppm
4 ppm
12
SWATH data file
HCP Ion
Library
Selected
Protein
Selected
Peptide
Acceptance Criteria
• 2 Peptides per protein
• 4 transitions per peptide
• FDR: 1.0%
• Peptide Confidence
Threshold > 99%
• MS/MS ppm: 20.0 ppm
• Score > 2
• 2/3 identification replication
SWATH
MS/MS
Library IDA
MS/MS
XIC – SWATH
MS/MS
SWATH Data File Processing in PeakView® SWATH™ microapp
Note: Protein selected is HCP ID 83
HCP Process Clearance Monitoring
Data Processing and Library Searching – Acceptance Criteria
13
83541324
TOF MS of
sample S3
indicating the
retention times of
identified HCP ID
83, 324, and 541.
S3 S4 S5 S6
HCP 83
HCP 324
HCP 541
XICs of
identified
HCPs
Note: XICs are generated from the sum of the top four transitions per peptide.
HCP Process Clearance Monitoring
Sample Analysis
14
Library ID S3 S4 S5 S6
48 100.00 4.67 2.74 ND
58 100.00 37.61 4.98 ND
83 100.00 1.26 0.19 ND
301 100.00 3.77 6.03 ND
324 100.00 3.83 0.64 0.76
541 100.00 32.97 30.47 31.28
672 100.00 6.83 3.36 ND
HCP Process Clearance Monitoring
HCP Clearance in Percentage-Step 3 through Step 6
HCPs present in S5 shown
17
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
S3 S4 S5 S6
%
Timepoint
HCP's Clearance in Percentage
48 58 83 301 324 541 672
Library ID S3 S4 S5 S6
48 5.74E+05 2.68E+04 1.58E+04 ND
58 6.25E+05 2.35E+05 3.11E+04 ND
83 1.27E+07 1.64E+06 2.38E+04 ND
301 3.81E+05 1.43E+04 2.30E+04 ND
324 2.17E+06 8.28E+04 1.38E+04 1.65E+04
541 1.87E+05 6.16E+04 5.70E+04 5.85E+04
672 3.18E+05 2.17E+04 1.07E+04 ND
HCP Process Clearance Monitoring
HCP Clearance in Area-Step 3 through Step 6
HCPs present in S5 shown
18
1.00E+04
1.00E+05
1.00E+06
1.00E+07
S3 S4 S5 S6
ProteinArea
Timepoint
Log Plot of HCP's Clearance in Area
48 58 83 301 324 541 672
HCP- Quantitation
Proof of Concept – Determining Performance Expectation
Six digested proteins were spiked into a mAb digest.
Dilutions were carried out maintaining [mAb].
*MS Qual/Quant QC Mix from Sigma-Aldrich P/N MSQC1
20
Values are ppm, 30 µg of mAb was loaded on column
11.6 ppm 2.32 ppm
HCP- Quantitation
Proof of Concept: Carbonic Anhydrase I, VLDALQAIK
0.464 ppm 0.0928 ppm
21
62 ppm 12.4 ppm
HCP- Quantitation
Proof of Concept: NAD(P)H dehydrogenase, EGHLSPDIVAEQK
2.48 ppm 0.496 ppm
22
46 ppm 9.2 ppm
HCP- Quantitation
Proof of Concept: C-reactive Protein, ESDTSYVSLK
1.84 ppm 0.368 ppm
23
24 ppm 4.8 ppm
HCP- Quantitation
Proof of Concept: Catalase, NLSVEDAAR
0.96 ppm 0.192 ppm
25
HCP- Quantitation
Proof of Concept - Determining Performance Expectation
Range established to sub ppm levels
Green = Confirmed; Red = Not Confirmed
Values are ppm, 30 µg of mAb was loaded on column
26
• CHO Database in place containing 4 CHO cell lines
• 3802 Proteins
• Generation of new HCP databases within ~2-3 months
• Identifications of HCPs for process monitoring can be
made < 1 ppm, and in some cases <100 ppb
•
• Thank you SCIEX for your support!
HCP– Analysis by Mass Spectrometry
SUMMARY
27

More Related Content

What's hot

Keeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) VirusKeeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) VirusMerck Life Sciences
 
Principle and applications of flow cytometry
Principle and applications of flow cytometryPrinciple and applications of flow cytometry
Principle and applications of flow cytometryDinesh Gangoda
 
Immunoprecipitation Presentation
Immunoprecipitation PresentationImmunoprecipitation Presentation
Immunoprecipitation PresentationVibhutiSardana1
 
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...Jonathan Clarke
 
Fluorescence- Activated Cell Sorter (FACS)
Fluorescence- Activated Cell Sorter (FACS)Fluorescence- Activated Cell Sorter (FACS)
Fluorescence- Activated Cell Sorter (FACS)Nidhi Parikh
 
Validation and verification of immunoassay methods dr. ali mirjalili
Validation and verification of immunoassay methods dr. ali mirjalili Validation and verification of immunoassay methods dr. ali mirjalili
Validation and verification of immunoassay methods dr. ali mirjalili Dr. Ali Mirjalili
 
Real time PCR
Real time PCRReal time PCR
Real time PCRnaren
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
RadioimmunoassayBangaluru
 
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsKBI Biopharma
 
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?Troubleshooting qPCR: What Are My Amplification Curves Telling Me?
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?Integrated DNA Technologies
 

What's hot (20)

Real time PCR
Real time PCRReal time PCR
Real time PCR
 
Technical Tips for qPCR
Technical Tips for qPCRTechnical Tips for qPCR
Technical Tips for qPCR
 
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) VirusKeeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
 
Principle and applications of flow cytometry
Principle and applications of flow cytometryPrinciple and applications of flow cytometry
Principle and applications of flow cytometry
 
Small molecule inhibitors
Small molecule inhibitorsSmall molecule inhibitors
Small molecule inhibitors
 
Primer Designing
Primer DesigningPrimer Designing
Primer Designing
 
Immunoprecipitation Presentation
Immunoprecipitation PresentationImmunoprecipitation Presentation
Immunoprecipitation Presentation
 
Real Time PCR
Real Time PCRReal Time PCR
Real Time PCR
 
Enzyme assays
Enzyme assaysEnzyme assays
Enzyme assays
 
real time-PCR..
real time-PCR..real time-PCR..
real time-PCR..
 
Real Time PCR
Real Time  PCRReal Time  PCR
Real Time PCR
 
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...
Reverse transcription-quantitative PCR (RT-qPCR): Reporting and minimizing th...
 
Immunoassays
ImmunoassaysImmunoassays
Immunoassays
 
Fluorescence- Activated Cell Sorter (FACS)
Fluorescence- Activated Cell Sorter (FACS)Fluorescence- Activated Cell Sorter (FACS)
Fluorescence- Activated Cell Sorter (FACS)
 
Immunoassay systems
Immunoassay systemsImmunoassay systems
Immunoassay systems
 
Validation and verification of immunoassay methods dr. ali mirjalili
Validation and verification of immunoassay methods dr. ali mirjalili Validation and verification of immunoassay methods dr. ali mirjalili
Validation and verification of immunoassay methods dr. ali mirjalili
 
Real time PCR
Real time PCRReal time PCR
Real time PCR
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet Methods
 
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?Troubleshooting qPCR: What Are My Amplification Curves Telling Me?
Troubleshooting qPCR: What Are My Amplification Curves Telling Me?
 

Similar to Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma

Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsMilliporeSigma
 
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-enPp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-enAlexander Boichenko
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...KBI Biopharma
 
Enhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m absEnhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m absOskari Aro
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryChris Suh
 
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 SystemQuantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 SystemSCIEX
 
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...PhinC Development
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Kate?ina Svobodov
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesKBI Biopharma
 
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...AliElmehdawi2
 
Bioanalytical method development and validation .
Bioanalytical method development and validation .Bioanalytical method development and validation .
Bioanalytical method development and validation .Shubham Bora
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copyIqrar Ansari
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsBruno Mmassy
 
BILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigBILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigGBX Events
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization KBI Biopharma
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesMilliporeSigma
 

Similar to Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma (20)

Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
 
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-enPp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
 
Enhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m absEnhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m abs
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant Library
 
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 SystemQuantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 System
 
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
 
Anaquant 20160701
Anaquant 20160701Anaquant 20160701
Anaquant 20160701
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
 
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p... Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
 
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
 
Bioanalytical method development and validation .
Bioanalytical method development and validation .Bioanalytical method development and validation .
Bioanalytical method development and validation .
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
 
GEN Reprint_LC1536
GEN Reprint_LC1536GEN Reprint_LC1536
GEN Reprint_LC1536
 
Pcrarray
PcrarrayPcrarray
Pcrarray
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology bls
 
BILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigBILS 2015 Christoph Herwig
BILS 2015 Christoph Herwig
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell Lines
 

More from KBI Biopharma

Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...KBI Biopharma
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...KBI Biopharma
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...KBI Biopharma
 
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...KBI Biopharma
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsKBI Biopharma
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...KBI Biopharma
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...KBI Biopharma
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...KBI Biopharma
 
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...KBI Biopharma
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesKBI Biopharma
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...KBI Biopharma
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationKBI Biopharma
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...KBI Biopharma
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingKBI Biopharma
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...KBI Biopharma
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...KBI Biopharma
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...KBI Biopharma
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...KBI Biopharma
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...KBI Biopharma
 
Characterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsCharacterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsKBI Biopharma
 

More from KBI Biopharma (20)

Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
 
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
 
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
 
Characterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsCharacterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeutics
 

Recently uploaded

Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxpradhanghanshyam7136
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 

Recently uploaded (20)

Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptx
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 

Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma

  • 1. a customer and science-focused contract development & manufacturing organization HOST CELL PROTEIN ANALYSIS BY MASS SPECTROMETRY Michael J Nold, Ph.D. Director, Mass Spectrometry Core Facility
  • 2. • Challenges with HCPs • HCP Spectral Library Generation • Process Clearance Monitoring HCP– Analysis by Mass Spectrometry Overview 2
  • 3. HCP– Analysis by Mass Spectrometry Challenges with HCPs • HCPs are impurities generated when recombinant proteins are manufactured. Recombinant proteins are frequently expressed in host cells from various cell lines. • Mammalian, Microbial, Bacterial, Yeast, Plant, Insect • Residual HCPs may affect product quality, safety and efficacy. • Toxicity, immune response to target, adjuvant effect, augment ADA response, bioactivity, product stability, product potency • Risks from a variety of factors • Dosing and dose frequency, patient demographics, route of administration
  • 4. HCP– Analysis by Mass Spectrometry Challenges with HCPs Many Challenges: • Variability of host cell substrates • Large number of protein analytes • Variability of protein population during upstream processing • Parental cell line, cell age, cell viability, feeding strategy, etc. • Dynamic range difference between DP and HCPs ( ≥e6 ) • Detection of HCPs that are not immunogenic à Immunoassay may miss these • HCP population can change during process development • HCPs may copurify with DP – “Hitchhiker” effect
  • 5. HCP– Analysis by Mass Spectrometry Challenges with HCPs Mass Spectrometry Challenges: • Column capacity, sample loading • DP overload on column • Mass spectrometer sensitivity • Dynamic range for ion detections • False positives, negatives • Ion statistics for identification, quantitation • Speed – Data to results to support process development • Does library reflect the process? • Time to generate a new library
  • 6. KBI HCP Reagents and Applications PHYSICAL CHEMICAL ATTRIBUTE #1 PHYSICAL CHEMICAL ATTRIBUTE #3 PHYSICAL CHEMICAL ATTRIBUTE #2 6
  • 7. HCP– MS Workflow Overview LCMS via ACQUITY/6600 TripleTOF Spectral Library Generation Sample Analysis Data Processing and Library Searching Data Independent Acquisition SWATH MS Data Dependent Acquisition LC-MS/MS CHO HCCF Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level Spectral Library 1% FDR Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level List of identified proteins and peptides Spectral library matching based on set search criteria and thresholds Sample 7
  • 8. HCP– MS Workflow Overview LCMS via ACQUITY/6600 TripleTOF Spectral Library Generation Sample Analysis Data Processing and Library Searching Data Independent Acquisition SWATH MS Data Dependent Acquisition LC-MS/MS CHO HCCF Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level Spectral Library 1% FDR Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level List of identified proteins and peptides Spectral library matching based on set search criteria and thresholds Sample 7
  • 9. HCP Spectral Library Generation Sample Preparation on the Protein and Peptide Level Process Samples 1D Analysis - No peptide level fractionation Process Samples 2D Analysis - High pH RP-HPLC peptide level fractionation Fraction 3 Fraction 2 Fraction 1 Fraction 4 Fraction 5 Peptide level fractionation of 5 of the 8 protein fractionated samples PHYSICAL CHEMICAL ATTRIBUTE #1 PHYSICAL CHEMICAL ATTRIBUTE #3 PHYSICAL CHEMICAL ATTRIBUTE #2 8
  • 10. HCP Spectral Library Generation Sample Load Optimization • Load Optimization Goal: achieve a dynamic range of ≥ 3 logs at the protein level for each experiment. • Utilize the ITC (ion transmission control) Count Conversion of the TOF MS TIC to determine the appropriate amount on column: optimized load when the TOF MS TIC apex is between 10-20%. • ITC: dynamically adjusts percent of the ion beam (voltage gate) according to an observed TIC signal to prevent saturation. • ITC Count Conversion plots the ITC voltage gate response: no signal / gate fully open = 100% saturation / gate fully closed = 0% TOF MS TIC – SWATH ITC Count Conversion of the TOF MS TIC – SWATH TOF MS TIC Apex 9
  • 11. 1.E+04 1.E+06 1.E+08 0 10 20 30 40 50 ProteinArea Protein Number Log Plot of Protein Dynamic Range HCP Spectral Library Generation Sample Load Optimization – Depth of Database • ADH: spiked in all samples at 300 fmol/µL**, used as a system suitability test and the signal response for relative quantitation. • PCM: spiked in all samples at 100 fmol/µL**, used as a retention time calibrator allowing for retention time alignment on any chromatographic system or timescale. ** Concentration of ADH and PCM is relative to 2 µg/µL of total HCP concentration. XIC - Yeast Alcohol Dehydrogenase (ADH) XIC - Peptide Calibration Mix (PCM) Graph generated using the HCPs identified in sample S3 to conceptually show the dynamic range of identified HCPs. 10
  • 12. HCP Spectral Library Generation IDA Library Data Collection and Processing ProteinPilot™ data processing w/ Paragon™ Algorithm. IDA spectral library Filter IDA spectral library based on acceptance criteria. • Acceptance Criteria for Library: • 1% FDR • No modifications or clipped peptides • Minimum of 2 peptide identifications per protein • Peptide Confidence Level: 95% • 10 ppm mass error tolerance • 2/2 identification replication Acquire IDA data in duplicate for each of 28 HCP samples/fractions. 11
  • 13. HCP Spectral Library Generation Contributions from 3 physiochemical preparations & fractionation Physiochemical Attribute 1 1850 Proteins Physiochemical Attribute 2 2925 Proteins Physiochemical Attribute 3 2137 Proteins 3802 Proteins 114 304 1047 598 976 385 378
  • 14. • HCPs are monitored from samples collected along a purification process, either for process development feedback, or monitoring a final process for one or more batches. • Samples are analyzed in triplicate, and identifications will have to meet a set of criteria at both peptide and protein levels. • Results include the list of identified HCPs, and relative quantitative information. • As an illustration, samples were obtained from the last four points of sampling from one of our programs. Protein A Viral Inactivation AEX* Based Polishing (Flow Through mode) CEX* Based Polishing Viral Filtration UF/DF Clarified Harvest *May be mixed mode S3 S4 S5 S6 HCP Process Clearance Monitoring Stand Alone, ELISA Support, or Process Development Support 7193 ppm 125 ppm 10 ppm 4 ppm 12
  • 15. SWATH data file HCP Ion Library Selected Protein Selected Peptide Acceptance Criteria • 2 Peptides per protein • 4 transitions per peptide • FDR: 1.0% • Peptide Confidence Threshold > 99% • MS/MS ppm: 20.0 ppm • Score > 2 • 2/3 identification replication SWATH MS/MS Library IDA MS/MS XIC – SWATH MS/MS SWATH Data File Processing in PeakView® SWATH™ microapp Note: Protein selected is HCP ID 83 HCP Process Clearance Monitoring Data Processing and Library Searching – Acceptance Criteria 13
  • 16. 83541324 TOF MS of sample S3 indicating the retention times of identified HCP ID 83, 324, and 541. S3 S4 S5 S6 HCP 83 HCP 324 HCP 541 XICs of identified HCPs Note: XICs are generated from the sum of the top four transitions per peptide. HCP Process Clearance Monitoring Sample Analysis 14
  • 17. Library ID S3 S4 S5 S6 48 100.00 4.67 2.74 ND 58 100.00 37.61 4.98 ND 83 100.00 1.26 0.19 ND 301 100.00 3.77 6.03 ND 324 100.00 3.83 0.64 0.76 541 100.00 32.97 30.47 31.28 672 100.00 6.83 3.36 ND HCP Process Clearance Monitoring HCP Clearance in Percentage-Step 3 through Step 6 HCPs present in S5 shown 17 0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 S3 S4 S5 S6 % Timepoint HCP's Clearance in Percentage 48 58 83 301 324 541 672
  • 18. Library ID S3 S4 S5 S6 48 5.74E+05 2.68E+04 1.58E+04 ND 58 6.25E+05 2.35E+05 3.11E+04 ND 83 1.27E+07 1.64E+06 2.38E+04 ND 301 3.81E+05 1.43E+04 2.30E+04 ND 324 2.17E+06 8.28E+04 1.38E+04 1.65E+04 541 1.87E+05 6.16E+04 5.70E+04 5.85E+04 672 3.18E+05 2.17E+04 1.07E+04 ND HCP Process Clearance Monitoring HCP Clearance in Area-Step 3 through Step 6 HCPs present in S5 shown 18 1.00E+04 1.00E+05 1.00E+06 1.00E+07 S3 S4 S5 S6 ProteinArea Timepoint Log Plot of HCP's Clearance in Area 48 58 83 301 324 541 672
  • 19. HCP- Quantitation Proof of Concept – Determining Performance Expectation Six digested proteins were spiked into a mAb digest. Dilutions were carried out maintaining [mAb]. *MS Qual/Quant QC Mix from Sigma-Aldrich P/N MSQC1 20 Values are ppm, 30 µg of mAb was loaded on column
  • 20. 11.6 ppm 2.32 ppm HCP- Quantitation Proof of Concept: Carbonic Anhydrase I, VLDALQAIK 0.464 ppm 0.0928 ppm 21
  • 21. 62 ppm 12.4 ppm HCP- Quantitation Proof of Concept: NAD(P)H dehydrogenase, EGHLSPDIVAEQK 2.48 ppm 0.496 ppm 22
  • 22. 46 ppm 9.2 ppm HCP- Quantitation Proof of Concept: C-reactive Protein, ESDTSYVSLK 1.84 ppm 0.368 ppm 23
  • 23. 24 ppm 4.8 ppm HCP- Quantitation Proof of Concept: Catalase, NLSVEDAAR 0.96 ppm 0.192 ppm 25
  • 24. HCP- Quantitation Proof of Concept - Determining Performance Expectation Range established to sub ppm levels Green = Confirmed; Red = Not Confirmed Values are ppm, 30 µg of mAb was loaded on column 26
  • 25. • CHO Database in place containing 4 CHO cell lines • 3802 Proteins • Generation of new HCP databases within ~2-3 months • Identifications of HCPs for process monitoring can be made < 1 ppm, and in some cases <100 ppb • • Thank you SCIEX for your support! HCP– Analysis by Mass Spectrometry SUMMARY 27